TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Takeda Pays $5.2 Billion for Leukemia Drug Maker Ariad, Ending Months of Takeout Speculation
STOCKS

Takeda pays $5.2B for leukemia drug maker Ariad

5 ETFs to Buy If You Love Bank of America's First-Quarter Earnings
OPINION

7 stocks seeing big volume -- and how to trade them from here

Shire Expects to Wrap Up Baxalta Buy on June 3
OPINION

Shire expects to wrap up Baxalta buy on june 3

Senator Debbie Stabenow Takes On Kid Rock and Michigan Pipeline On The Same Day
OPINION

4 stock picks to buy now, from energy to biotech

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled
STOCKS

Allergan could buy these drug companies now that Pfizer merger is scuttled

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: I'm Taking Starbucks Over Bojangles

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Uncle Sam, Back Off Business!

Mitel to Acquire ShoreTel
MARKETS

European stocks rise, led by health care

Shire Expects to Wrap Up Baxalta Buy on June 3
MARKETS

Baxalta (BXLT) Stock Up as Shire Remains Committed to Merger

Trading the Bear Market in Global Equities
MARKETS

European stocks stabilize as health care gains

Aetna (AET), Humana $37B Deal Rejected, CNBC's Faber Says
STOCKS

Here are the 6 biggest M&A deals in the first quarter.

JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
OPINION

7 stocks spiking on big volume

Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results
MARKETS

Baxalta (BXLT) Stock Gains in Pre-Market Trading on Earnings Beat

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: Sell Marathon Petroleum and Tiffany

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Don't panic, start buying

Jim Cramer's Top Takeaways: CST Brands, Chemours, Adobe, Salesforce, Workday
OPINION

Jim Cramer's Top Takeaways: WhiteWave, PayPal, Starbucks, General Electric

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Sit tight and wait

These 10 S&P 500 Companies Have the Best Performing Stocks in 2016
STOCKS

These S&P 500 stocks are the best performers in 2016.

Pearson Plummets on Lower Guidance; Other Publishers Offer Better Investment Opportunities
STOCKS

A lack of news and buzz at 'JPM16' sinks biotech stocks

Shire to Acquire Biopharma Company Baxalta in $32B Deal
VIDEO

Shire to Acquire Biopharma Company Baxalta in $32B Deal

Midday Report: U.S. Stocks Slip; 'Star Wars' Leads Chinese Box Office
VIDEO

Midday Report: U.S. Stocks Slip; 'Star Wars' Leads Chinese Box Office

Stocks Grind Even Higher as Microsoft, Visa Lead Dow
MARKETS

stocks reverse direction as energy sector falls

PACCAR (PCAR) Stock Down Following Q4 Earnings
MARKETS

Baxalta (BXLT) Stock Up, Shire Acquiring For $32 Billion, Jim Cramer's Take

S&P 500 on Track for Record Close as Crude Closes Higher
MARKETS

stock futures rise despite another chinese market drop

Sina Stock Falls in After-Hours Trading After Reporting Q1 Results
MARKETS

Why Baxalta (BXLT) Stock is Up Today